Related Experiment Video

Updated: Jun 6, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

F2-isoprostanes as an indicator and risk factor for coronary heart disease

Sean S Davies1, L Jackson Roberts

  • 1Division of Clinical Pharmacology and Department of Pharmacology, Vanderbilt University, Nashville, TN 37221, USA. sean.davies@vanderbilt.edu

Free Radical Biology & Medicine
|December 4, 2010
PubMed

Insights

F(2)-isoprostanes, products of polyunsaturated fatty acid oxidation, show promise as biomarkers for detecting coronary heart disease (CHD). Monitoring these lipid peroxidation products could improve risk assessment and management of atherosclerosis.

Area of Science:

  • Cardiovascular Science
  • Biomarker Discovery
  • Oxidative Stress Research

Background:

  • Coronary heart disease (CHD) is a leading cause of death in Western countries.
  • Atherosclerosis, the underlying cause of CHD, develops gradually and can be influenced by interventions.
  • Related vascular diseases like stroke and heart failure share common atherosclerotic processes.

Purpose of the Study:

  • To review the evidence for F(2)-isoprostanes as biomarkers for CHD.
  • To explore the potential of monitoring lipid peroxidation products in assessing atherosclerosis risk.
  • To highlight the role of PUFA oxidation in CHD development.

Main Methods:

  • Review of scientific literature on F(2)-isoprostanes and atherosclerosis.
  • Analysis of studies investigating lipid peroxidation products as CHD indicators.
  • Focus on the link between polyunsaturated fatty acid (PUFA) oxidation and cardiovascular disease.

Main Results:

  • Oxidation of PUFAs in plasma lipoproteins is implicated in atherosclerosis development.
  • F(2)-isoprostanes are specific products of PUFA peroxidation.
  • Evidence suggests F(2)-isoprostanes may serve as useful biomarkers for CHD risk.

Conclusions:

  • F(2)-isoprostanes represent a potential tool for detecting subclinical atherosclerosis.
  • Monitoring F(2)-isoprostanes could aid in managing CHD and related vascular diseases.
  • Further research into F(2)-isoprostanes may lead to improved CHD prevention and treatment strategies.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...